Number of patients | 31 |
---|---|
Mean age (years (SD)) | 62.8 (11.7) |
Male sex, n (%) | 26 (83.9) |
Disease history, n (%) | |
Hypertension | 17 (54.8) |
Angina pectoris | 23 (74.2) |
Previous myocardial infarction | 5 (16.1) |
Anterior myocardial infarction | 16 (51.6) |
Maximum level of CK (U/l, mean (SD)) | 3578 (2589) |
Forrester subset II, III, IV on admission, n (%) | 9 (31.0) |
Killip class II, III, IV on admission, n (%) | 8 (25.8) |
Time after onset to admission (h, mean (SD)) | 3.8 (3.9) |
Medication during protocol, n (%) | |
Nitrates | 16 (51.6) |
Calcium channel antagonists | 24 (77.4) |
ACE inhibitors | 9 (29.0) |
Treatment in acute phase, n (%) | |
PTCR | 22 (71.0) |
Direct PTCA | 3 (9.7) |
ACE, angiotensin converting enzyme; CK, creatine kinase; PTCR, percutaneous transluminal coronary recanalisation; PTCA, percutaneous transluminal coronary angioplasty.